Compare RIOT & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RIOT | ARWR |
|---|---|---|
| Founded | 2000 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 10.2B |
| IPO Year | 2002 | 2009 |
| Metric | RIOT | ARWR |
|---|---|---|
| Price | $20.60 | $85.17 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 10 |
| Target Price | $25.43 | ★ $83.40 |
| AVG Volume (30 Days) | ★ 14.9M | 1.9M |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 99.80 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $647,435,000.00 | $16,142,321.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $24.12 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 71.89 | N/A |
| 52 Week Low | $10.59 | $14.30 |
| 52 Week High | $30.32 | $87.83 |
| Indicator | RIOT | ARWR |
|---|---|---|
| Relative Strength Index (RSI) | 32.40 | 63.17 |
| Support Level | $12.46 | $70.05 |
| Resistance Level | $24.43 | N/A |
| Average True Range (ATR) | 2.16 | 4.04 |
| MACD | -0.98 | 0.62 |
| Stochastic Oscillator | 0.82 | 78.03 |
Riot Platforms Inc is a vertically integrated digital infrastructure company principally engaged in developing and optimizing its large-scale power assets. The Company's business centers on enhancing its electrical infrastructure and deploying it across two complementary platforms: (i) Bitcoin Mining and (ii) scalable data center solutions designed to support non-mining workloads. The company's segments include Bitcoin Mining and Engineering. The Bitcoin Mining segment generates revenue from the Bitcoin the Company earns through its Bitcoin Mining activities. The Engineering segment generates revenue through customer contracts for custom engineered electrical products. It generates the majority of its revenue from the Bitcoin Mining segment.
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.